NSRX
NSRX
AMEX · Pharmaceuticals

Nasus Pharma Ltd

$2.97
+0.06 (+2.06%)
As of Nov 7, 2:38 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,389.2% upside
Low Target $32.29
Average Target $44.23
High Target $55.91
Current Price $2.97
Current
$2.97
Target
$44.23
$32.29 $44.23 avg $55.91
Scenario Analysis
Bear Case
$32.29
987.2%
Low target
Base Case
$44.23
+1,389.2%
Avg target
Bull Case
$55.91
+1,782.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$9.50
-68.7% from high
52-Week Low
$1.98
+50.0% from low
Target vs 52W High
$44.23
+365.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%